Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction
NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course.
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article/Letter to editor biblioteca |
Language: | English |
Subjects: | NGLY1, OXPHOS enzyme activity, Seahorse respirometry, Whole exome sequencing, mitochondrial disorders, |
Online Access: | https://research.wur.nl/en/publications/variants-in-ngly1-lead-to-intellectual-disability-myoclonus-epile |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-623227 |
---|---|
record_format |
koha |
spelling |
dig-wur-nl-wurpubs-6232272025-01-15 Panneman, Daan M. Wortmann, Saskia B. Haaxma, Charlotte A. van Hasselt, Peter M. Wolf, Nicole I. Hendriks, Yvonne Küsters, Benno van Emst-de Vries, Sjenet van de Westerlo, Els Koopman, Werner J.H. Wintjes, Liesbeth van den Brandt, Frans de Vries, Maaike Lefeber, Dirk J. Smeitink, Jan A.M. Rodenburg, Richard J. Article/Letter to editor Clinical Genetics 97 (2020) 4 ISSN: 0009-9163 Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction 2020 NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course. en text/html https://research.wur.nl/en/publications/variants-in-ngly1-lead-to-intellectual-disability-myoclonus-epile 10.1111/cge.13706 https://edepot.wur.nl/644907 NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
language |
English |
topic |
NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders |
spellingShingle |
NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders Panneman, Daan M. Wortmann, Saskia B. Haaxma, Charlotte A. van Hasselt, Peter M. Wolf, Nicole I. Hendriks, Yvonne Küsters, Benno van Emst-de Vries, Sjenet van de Westerlo, Els Koopman, Werner J.H. Wintjes, Liesbeth van den Brandt, Frans de Vries, Maaike Lefeber, Dirk J. Smeitink, Jan A.M. Rodenburg, Richard J. Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
description |
NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway. Variants in this gene have been described to cause a multisystem disease characterized by neuromotor impairment, neuropathy, intellectual disability, and dysmorphic features. Here, we describe four patients with pathogenic variants in NGLY1. As the clinical features and laboratory results of the patients suggested a multisystem mitochondrial disease, a muscle biopsy had been performed. Biochemical analysis in muscle showed a strongly reduced ATP production rate in all patients, while individual OXPHOS enzyme activities varied from normal to reduced. No causative variants in any mitochondrial disease genes were found using mtDNA analysis and whole exome sequencing. In all four patients, variants in NGLY1 were identified, including two unreported variants (c.849T>G (p.(Cys283Trp)) and c.1067A>G (p.(Glu356Gly)). Western blot analysis of N-glycanase in muscle and fibroblasts showed a complete absence of N-glycanase. One patient showed a decreased basal and maximal oxygen consumption rates in fibroblasts. Mitochondrial morphofunction fibroblast analysis showed patient specific differences when compared to control cell lines. In conclusion, variants in NGLY1 affect mitochondrial energy metabolism which in turn might contribute to the clinical disease course. |
format |
Article/Letter to editor |
topic_facet |
NGLY1 OXPHOS enzyme activity Seahorse respirometry Whole exome sequencing mitochondrial disorders |
author |
Panneman, Daan M. Wortmann, Saskia B. Haaxma, Charlotte A. van Hasselt, Peter M. Wolf, Nicole I. Hendriks, Yvonne Küsters, Benno van Emst-de Vries, Sjenet van de Westerlo, Els Koopman, Werner J.H. Wintjes, Liesbeth van den Brandt, Frans de Vries, Maaike Lefeber, Dirk J. Smeitink, Jan A.M. Rodenburg, Richard J. |
author_facet |
Panneman, Daan M. Wortmann, Saskia B. Haaxma, Charlotte A. van Hasselt, Peter M. Wolf, Nicole I. Hendriks, Yvonne Küsters, Benno van Emst-de Vries, Sjenet van de Westerlo, Els Koopman, Werner J.H. Wintjes, Liesbeth van den Brandt, Frans de Vries, Maaike Lefeber, Dirk J. Smeitink, Jan A.M. Rodenburg, Richard J. |
author_sort |
Panneman, Daan M. |
title |
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
title_short |
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
title_full |
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
title_fullStr |
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
title_full_unstemmed |
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
title_sort |
variants in ngly1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction |
url |
https://research.wur.nl/en/publications/variants-in-ngly1-lead-to-intellectual-disability-myoclonus-epile |
work_keys_str_mv |
AT pannemandaanm variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT wortmannsaskiab variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT haaxmacharlottea variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT vanhasseltpeterm variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT wolfnicolei variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT hendriksyvonne variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT kustersbenno variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT vanemstdevriessjenet variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT vandewesterloels variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT koopmanwernerjh variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT wintjesliesbeth variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT vandenbrandtfrans variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT devriesmaaike variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT lefeberdirkj variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT smeitinkjanam variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction AT rodenburgrichardj variantsinngly1leadtointellectualdisabilitymyoclonusepilepsysensorimotoraxonalpolyneuropathyandmitochondrialdysfunction |
_version_ |
1822267134915379200 |